Application of the relationship between pharmacokinetics and pharmacodynamics in drug development and therapeutic equivalence: a PEARRL review

The Journal of Pharmacy and Pharmacology
Ioannis Loisios-KonstantinidisJennifer Dressman

Abstract

The objective of this review was to provide an overview of pharmacokinetic/pharmacodynamic (PK/PD) models, focusing on drug-specific PK/PD models and highlighting their value added in drug development and regulatory decision-making. Many PK/PD models, with varying degrees of complexity and physiological understanding have been developed to evaluate the safety and efficacy of drug products. In special populations (e.g. paediatrics), in cases where there is genetic polymorphism and in other instances where therapeutic outcomes are not well described solely by PK metrics, the implementation of PK/PD models is crucial to assure the desired clinical outcome. Since dissociation between the pharmacokinetic and pharmacodynamic profiles is often observed, it is proposed that physiologically based pharmacokinetic and PK/PD models be given more weight by regulatory authorities when assessing the therapeutic equivalence of drug products. Modelling and simulation approaches already play an important role in drug development. While slowly moving away from 'one-size fits all' PK methodologies to assess therapeutic outcomes, further work is required to increase confidence in PK/PD models in translatability and prediction of various clinical sc...Continue Reading

References

Nov 1, 1978·British Journal of Anaesthesia·C J HullM J Watson
Mar 1, 1979·Clinical Pharmacology and Therapeutics·L B SheinerJ Ham
Sep 1, 1976·Clinical Pharmacology and Therapeutics·R L GaleazziL B Sheiner
Feb 1, 1976·British Journal of Anaesthesia·V A GoatS A Feldman
Dec 1, 1992·The Journal of Pediatrics·R E Kauffman, M V Nelson
Mar 1, 1992·Journal of Clinical Pharmacology·R D BrownK M Bertrand
Oct 1, 1991·Pharmacology & Therapeutics·G Labrecque, P M Bélanger
Jul 1, 1989·Clinical Pharmacology and Therapeutics·P D WalsonL Alexander
Jan 16, 1985·Biochemical and Biophysical Research Communications·W B ImJ P Davis
Jul 1, 1986·Clinical Pharmacology and Therapeutics·E M LaskaN McCormick
Nov 1, 1986·Pharmacotherapy·A K JainC Noveck
Aug 1, 1986·Journal of Pharmacokinetics and Biopharmaceutics·J L GabrielssonL K Paalzow
Jan 1, 1969·Clinical Pharmacology and Therapeutics·R NagashimaG Levy
Dec 22, 1983·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·J W Black, P Leff
Jan 1, 1984·European Journal of Clinical Pharmacology·M A EvansE J Triggs
Jan 1, 1982·Pharmacology & Therapeutics·N H Holford, L B Sheiner
Jun 1, 1983·Clinical Pharmacology and Therapeutics·R A MorrisonH L Fung
Jun 1, 1982·The Journal of Clinical Investigation·P PatrignaniC Patrono
Oct 1, 1981·British Journal of Clinical Pharmacology·B WhitingG J Addis
Apr 1, 1980·Journal of Pharmacokinetics and Biopharmaceutics·A W Kelman, B Whiting
Jul 1, 1995·Clinical Pharmacology and Therapeutics·D R MouldI H Patel
Oct 1, 1994·Clinical Pharmacology and Therapeutics·W J Jusko, H C Ko
Aug 1, 1993·Journal of Pharmacokinetics and Biopharmaceutics·N L DaynekaW J Jusko
Oct 1, 1993·Clinical Pharmacology and Therapeutics·K H LewW J Jusko
Dec 1, 1993·Oral Surgery, Oral Medicine, and Oral Pathology·E V HershE Henry
Jan 1, 1994·Clinical Pharmacology and Therapeutics·V Garg, W J Jusko
Jun 5, 1993·Biochimica Et Biophysica Acta·J M ShinG Sachs
Jul 1, 1996·Clinical Pharmacology and Therapeutics·M WakelkampG Paintaud
Oct 1, 1996·Journal of Clinical Pharmacology·S RohatagiH Derendorf
May 15, 1997·Biochemical Pharmacology·D M Ouellet, G M Pollack
Dec 24, 1997·Journal of Pharmacological and Toxicological Methods·E H CoxM Danhof

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.